Experts Discuss Novel RAS-Targeted Therapy for Pancreatic Cancer
Listen to Nilofer Azad, MD, FASCO, and Zev A. Wainberg, MD, as they discuss novel RAS-targeted therapies for pancreatic cancer, including optimal KRAS mutation testing, emerging multiselective RAS inhibitors, and combination strategies.
Decera Clinical Education Oncology Podcast · Nilofer Azad MD FASCO, Zev A. Wainberg MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast episode, Nilofer Azad, MD, FASCO, and Zev A. Wainberg, MD, discuss novel RAS-targeted therapies for pancreatic cancer, including the following:
- Optimal KRAS mutation testing
- Emerging multiselective RAS inhibitors
- Combination strategies
Presenters:
Nilofer Azad, MD, FASCO
Professor of Oncology
Associate Director of Clinical Research
Sidney Kimmel Cancer Center at Johns Hopkins University
Co-Leader, Developmental Therapeutics Clinical Trials Group
Baltimore, Maryland
Zev A. Wainberg, MD
Professor of Medicine and Surgery
Co-Director, GI Oncology Program
UCLA School of Medicine
Los Angeles, California
Content based on an online CME program supported by an educational grant from Revolution Medicines, Inc.
Link to full program:
https://bit.ly/4avdRZK
Get access to all our new podcasts by subscribing to the Decera Clinical Education Oncology Podcast on Apple Podcasts, YouTube Music, or Spotify.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.